Remove 2014 Remove Chemotherapy Remove Immunity
article thumbnail

Company profile: NeoImmuneTech

pharmaphorum

Amplifying and reinvigorating persistent T cell immunity has become a much-needed path to enhance anti-tumor efficacy. T cells are known to mediate anti-tumor immune responses. For that reason, they have become the key target of immune checkpoint therapies, like PD-(L)1 agents. Creation: Jan. Areas of expertise: Immuno-Oncology.

article thumbnail

Advancing cell therapies – ?? T cells and the combination factor

European Pharmaceutical Review

Our work is establishing whether it is possible to use allogeneic innate immune cells from a healthy donor to support the immune system of a person with cancer in combatting the condition. T cells are the first line of defence in the immune system to eradicate diseases. such as a chimeric antigen receptor (CAR). In response, ??

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Microbiome therapies: a maturing movement

European Pharmaceutical Review

How do you envision microbiome therapies complementing existing cancer treatments, such as chemotherapy and immunotherapy? About the interviewees Hervé Affagard is the CEO and co-founder of MaaT Pharma, which was established in late 2014. Trials of faecal microbiota transplantation (FMT) have demonstrated proof-of-concept in UC.

Immunity 105
article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

“If we work closely with government stakeholders and possibly collaborate on developing innovative access schemes for rare diseases, cancers, immune and inflammatory disorders, we can encourage greater participation by established biopharmas and stimulate the growth of entrepreneurial local companies in the region.”. million in 2030.

article thumbnail

AstraZeneca acquires TeneoTwo in $1.3bn deal to broaden haematology portfolio

Pharmaceutical Technology

Moreover, a deeper understanding of immune evasion by cancer cells may provide novel sensitization strategies to further enhance the clinical response of BiTEs. . The confirmatory Phase III TOWER trial demonstrated superior overall survival in R/R B-ALL patients with Blincyto versus conventional chemotherapy (7.7 months vs. 4.0

article thumbnail

Fluoride And Your Thyroid

The Thyroid Pharmacist

They include anesthetics, antacids, anti-anxiety medications, antibiotics, antidepressants, antifungals, cholesterol-lowering medications, anti-malarial medications, chemotherapy, appetite suppressants, arthritis medications, psychotropics, and steroids. Published 2014 Jan 3. Published 2014 Jan 3. Springerplus. Springerplus.

article thumbnail

How Myo-inositol Can Improve Hashimoto’s Symptoms

The Thyroid Pharmacist

12) For anyone looking to support immune health, hormone balance, and metabolic health, in addition to their thyroid, this is a great option. (37-39) Selenium may also interact with other supplements and medications, such as cholesterol-lowering statin drugs, antacids, chemotherapy drugs, corticosteroids, niacin, and even birth control pills.